Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
Current assets:    
Cash $ 9,118,564 $ 28,644,004
Accounts receivable, net 17,605 15,794
Inventory 297,500 821,549
Prepaid expenses and other 1,183,714 565,174
Total current assets 10,617,383 30,046,521
Property and equipment 2,026,895 1,441,229
Less accumulated depreciation and amortization 1,092,317 977,960
Property and equipment, net 934,578 463,269
Patents and trademarks 115,053 106,592
Less accumulated amortization 22,571 21,171
Patents and trademarks, net 92,482 85,421
Deferred debt issuance costs and other 327,954 598,709
Total assets 11,972,397 31,193,920
Current liabilities:    
Accounts payable 1,417,463 681,754
Accrued liabilities and other 2,016,358 2,097,786
Notes payable, current, net of discount of $202,287 2,756,718   
Derivative liabilities    568,930
Total current liabilities 6,190,539 3,348,470
Notes payable, net of discounts of $93,038 and $543,612, respectively 6,930,112 6,456,388
Other liabilities 257,122 257,315
Total liabilities 13,377,773 10,062,173
Commitments and contingencies      
Stockholders' (deficit) equity:    
Preferred stock; $.001 par value; 5,000,000 shares authorized; 6,938 and 9,083 Series B shares, and 0 and 1,000 Series C shares issued and outstanding at December 31, 2012 and 2011, respectively 7 10
Common stock; $.001 par value; 200,000,000 shares authorized; 113,018,772 and 95,398,961 shares issued and outstanding at December 31, 2012 and 2011, respectively 113,019 95,399
Additional paid-in capital 273,039,442 266,393,645
Accumulated deficit (274,557,844) (245,357,307)
Total stockholders' (deficit) equity (1,405,376) 21,131,747
Total liabilities and stockholders' (deficit) equity $ 11,972,397 $ 31,193,920